SCHEMBL6899080

SCHEMBL6899080

COC(=O)C(C)(CCCCC[S+]([O-])CCCCCC(C)(C(=O)O)c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.41
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
OPRM1 P35372 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
OPRD1 P41143 1/20 0.33
CCR1 P32246 1/20 0.33
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM5 P08912 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6506729 0.96 KCNN4 (0.44) KCNN4HDAC3HDAC4HDAC1HDAC7
SCHEMBL6511721 0.91 CYP2C19 (0.38) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6509946 0.89 CYP2C19 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL27578211 0.86 KCNN4 (0.34) KCNN4PRSS1CTSGCTRB1CMA1
SCHEMBL6508892 0.85 CYP2C19 (0.40) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6700913 0.82 CYP2C19 (0.38) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6698317 0.81 CYP2C19 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4955211 0.80 KCNN4 (0.49) KCNN4PRSS1CTSGCTRB1CMA1
SCHEMBL6508061 0.80 HDAC3 (0.35) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6691110 0.79 CES1 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673780-B2 SUCH AS 4-(4-(3-HYDROXY-3-METHYL-BUTANE-1-SULFINYLMETHYL)-PHENYLMETHANESULFINYL)-2 -METHYL-BUTAN1-OL FOR TREATING AND PREVENTING CARDIOVASCULAR DISEASES, DYSLIPIDEMIAS, DYSPROTEINEMIAS, AND GLUCOSE METABOLISM DISORDERS ESPERION THERAPEUTICS, INC. 2004-01-06 US disclosed